According to the new market research report “Medical Decision Support Systems for Sepsis Market: Revolutionary Primer for Clinical Decision Support (Market Dynamics, Case Studies, Regional Analysis (North America, Europe, Asia Pacific, Rest of the World)) – Global Forecast” published by MarketsandMarkets™.
The Global Medical Decision Support Systems for Sepsis Market is projected to reach USD 35.6 Million, at a CAGR of 24.3%.
Major Market Growth Drivers:
- Increasing Funding and Research Grants
- Growing Presure to Curb Healthcare Spending and Improve Patient Outcomes
- Machine Learning and Artificial Intelligence in Clinical Decision Support Systmes
Browse 3 market data Tables and 3 Figures spread through 65 Pages and in-depth TOC | Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=227232851
Target Audience For the Research Report:
- Healthcare institutions/providers (hospitals, medical groups, physician practices, diagnostic centers, pharmacies, ambulatory centers, and outpatient clinics)
- Healthcare insurance companies/payers
- Healthcare it service providers
- Venture capitalists
- Government bodies
Increasing funding & research grants, growing pressure to curb healthcare spending, and improving patient outcomes are the major factors propelling the growth of the market. In addition, machine learning & artificial intelligence in CDSS is posing as a lucrative opportunity for the market in the coming years.
Various players in the market offer sepsis CDS solutions embedded in their EHR while there are others who offer separate surveillance solutions for sepsis.
North America dominated the market.
Geographically, the global medical decision support systems for sepsis market is divided into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share in 2017 owing to factors such as rising incidence of sepsis, focus of major players in the region and increasing investment in HCIT expenditure.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227232851
Wolters Kluwer Health (US), Cerner Corporation (US), Philips Healthcare (Netherlands), Amara Health Analytics (US), McKesson Corporation (US), Ambient Clinical Analytics (US), Iatric Systems Inc. (US), PeraHealth Inc. (US), Health Catalyst Inc. (US), and Allscripts Healthcare Solutions, Inc. (US) are the key players in the global medical decision support systems for sepsis market.
The report “Medical Decision Support Systems for Sepsis Market Revolutionary Primer for Clinical Decision Support (Market Dynamics, Case Studies, Regional Analysis (North America, Europe, Asia Pacific, Rest of the World)) – Global Forecast to 2022″, The MDSS for Sepsis Market is expected to reach USD 35.6 Million, at a CAGR of 24.3%.Increasing funding & research grants, growing pressure to curb healthcare spending, and improving patient outcomes are the major factors propelling the growth of the market.
In addition, machine learning & artificial intelligence in CDSS is posing as a lucrative opportunity for the market in the coming years.Various players in the market offer sepsis CDS solutions embedded in their EHR while there are others who offer separate surveillance solutions for sepsis.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227232851Objectives of the Study:– To define, describe, and forecast the global medical decision support systems for sepsis market on the basis of region– To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)– To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market– To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders– To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the WorldGeographically, the North American market accounted for the largest share in 2017 and is expected to register the highest CAGR during the forecast period.
The large share and high growth can be attributed to factors such as increasing efforts to curb healthcare spending, federal initiatives such as the Hospital Readmissions Reduction Program, and rising investments in HCIT solutions in the country.
Major players providing sepsis CDS modules include Cerner, Epic, and MEDITECH.
Third-party vendors like VigiLanz, Iatric Systems, and PeraHealth are also based out of the US.
The presence of these key players in the country has made the US a center of innovation in the CDSS market.
It provides valuable information on the type, procedure, application, and region in the market.
This can be attributed to the benefits of internal neuromodulation technologies, such as reductions in post-surgical complications and length of hospital stay, as well as long-term cost savings associated with the use of internal neuromodulation devices.
Based on type, the External Neuromodulation is segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES).
This is mainly due to the higher incidence of chronic disorders, the wide range of applications of these devices, their cost-effectiveness, and the rising demand for non-invasive therapy.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=921 The prominent players in this market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), and LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel).
Medtronic (Ireland) dominated the global neuromodulation market.
